Thats a critical distinction, because it means these patches do not actually contain the active GLP-1 medications responsible for the weight-loss effects seen in clinical trials
The in vitro neutralizing activity of the antibodies is uncertain at this time
A sterile gauze pad (usually 2 x 2 inches) A sterile adhesive bandage (note - make sure the patient is not allergic to the adhesive, as can lead to irritation near the wound) A clean towel Most subcutaneously-injected medications are clear and come in similarly-sized containers
Setting and recruitment This trial will take place at a single academic center, Mount Sinai Hospital (MSH) in Toronto, Canada
Furthermore, AOD-9604 has shown promise in promoting cartilage repair, reducing inflammation, and improving joint health, broadening its potential therapeutic applications